US · Healthcare · Biotechnology
EPS came in at -0.21 against a street estimate of -0.20 — a miss of 5.0%.
Analysts rate Absci Corp a strong buy (9 buy, 0 hold, 0 sell out of 9) with an average price target of $14.22.
| Fund | Stake |
|---|---|
| FMR Inc | 13.14% |
| ARK Investment Management LLC | 8.00% |
| BlackRock Inc | 6.56% |
| State Street Corp | 4.27% |
| Redmile Group, LLC | 3.93% |
| Vanguard Capital Management, LLC | 3.43% |
| Advanced Micro Devices Inc | 3.33% |
| Adage Capital Partners Gp LLC | 3.32% |
| Document | Date |
|---|---|
| Quarterly report · Q2 2026 ABSCI CORPORATION - QUARTERLY SUMMARY (Q2 2026) HEADLINE NUMBERS • Cash position: $107.9 million in cash and cash equivalents as of June 30, 2026, u | 2026-08-11 |
| Results announced · Q3 2026 ABSCI CORPORATION – Q2 2026 FINANCIAL & OPERATING SUMMARY HEADLINE NUMBERS • Cash Position: $201.1 million in cash, cash equivalents, and marketable | 2026-08-11 |
| Material agreement · Q2 2026 ABSCI CORPORATION – 8-K SUMMARY HEADLINE NUMBERS • Stock offering size: 13,495,277 shares of common stock • Offering price: $7.41 per share • Gross | 2026-06-24 |
| Company announcement · Q2 2026 ABSCI CORPORATION (ABSI) - FORM 8-K SUMMARY HEADLINE NUMBERS • Company announced Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201 on June 24 | 2026-06-24 |
| Shareholder vote results · Q2 2026 ABSCI CORPORATION – FORM 8-K SUMMARY HEADLINE NUMBERS • Outstanding shares as of record date (April 7, 2026): 155,447,428 shares of common stock • A | 2026-06-05 |
| Quarterly report · Q1 2026 ABSCI CORPORATION – Q1 2026 SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Cash & Liquidity Crisis: Cash and cash equivalents dropped 57% to $8.6 m | 2026-05-07 |
| Proxy statement · Q2 2026 ABSCI CORPORATION PROXY STATEMENT SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1 – Election of Two Class II Directors: Vote to elect Prof Sir | 2026-04-22 |
| Annual report FY2025 ABSCI CORPORATION — 2025 ANNUAL REPORT SUMMARY HEADLINE NUMBERS • Public company trading on NASDAQ under ticker ABSI; fiscal year ended December 31, | 2026-03-24 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Absci Corp — free to start.
Google PlayApp StoreData updated 2026-09-18.